Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
about
Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.MUC1-C activates EZH2 expression and function in human cancer cells.
P2860
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@en
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@nl
type
label
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@en
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@nl
prefLabel
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@en
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2.
@nl
P2093
P2860
P1433
P1476
Chronic Myelogenous Leukemia- Initiating Cells Require Polycomb Group Protein EZH2
@en
P2093
Elenoe C Smith
Huafeng Xie
James E Bradner
Jialiang Huang
Minh Nguyen
Partha P Das
Shaoguang Li
P2860
P304
P356
10.1158/2159-8290.CD-15-1439
P577
2016-09-14T00:00:00Z